From the certificate to the registry hash.
A lab or QA manager reads the numbers everyone else takes on trust. This order starts with the grade vocabulary, takes a certificate apart, works through the total-THC arithmetic and the heat step, and ends where the platform's own numbers come from.
7 pages, in the order that makes the next one easier.
A path is a reading order, not a course. Each step is a page that already exists, with one line on why it comes where it does. Read them in sequence and the self-check at the end should hold no surprises.
How we grade
Every page after this one uses the same six rungs and two off-ladder states. Ten minutes here and no chip on the site will surprise you.
Page 1 of 7The certificate of analysis
A specimen certificate, taken apart panel by panel: what each line measures, and which ones a buyer should refuse to buy without.
Page 2 of 7THCA and total THC
Delta-9 only or total THC: the arithmetic that decides whether a sample is hemp, and why the same certificate can read differently by jurisdiction.
Page 3 of 7Heat and decarboxylation
What heat does to the acid fraction between the sample and the result, on the same chemistry the THCA page states.
Page 4 of 7CBN and ageing THC
Rising CBN in stored material is a sign the THC is ageing. The sleep trial record is the other reason to read this page.
Page 5 of 7The research library
Every graded study with its tier and provenance hash, and the registry hash that every page on the site shares.
Page 6 of 7Corrections
How the record changes when it changes: a visible log rather than a silent edit.
Page 7 of 7
5 questions, each answered somewhere on the path.
Pick one option per question and press Check. Every correct answer is a fact the site documents, and the feedback links to the page that documents it. Checking runs in your browser; nothing is scored, stored or sent anywhere.
The other three orders.
Formulator · Brand owner · Buyer, consumer or retail. Or start from how we grade, the page every path shares.
The blood-pressure note that appears on CBG pages is mechanistic and safety-relevant, not a benefit claim. CBG shows potent α2-adrenoceptor agonism in vitro, and α2 agonists can lower blood pressure — but no study has measured an actual blood-pressure effect of CBG. If you take blood-pressure medication or have a cardiovascular condition, consult a clinician first.
A learning path orders pages; it does not advise. Nothing on it is a claim that any product does anything for any disease. If you have experienced a possible adverse effect from a cannabinoid product, use the Report a safety event path. Peregrine Biopharma funds the platform and holds no editorial authority.